← Leaderboards
Eric Gary Schmuck
Cellular Logistics Inc.
$497,433
Attributed
$657,772
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $337.1K · FY2021–22$500K$375K$250K$125K$0
'21
'22
Funding mix
By agency
NIH$657,772 · 2
By mechanism
R43$657,772 · 2
Top collaborators
- Timothy J Kamp1 shared
Others in their field
Other Emerging Leaders on “Heart Failure”
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,153,043
- Ionut Bebu · George Washington University$9,972,097
- Barbara Halina Braffett · George Washington University$9,972,097
- Bing Yu · University Of Tx Md Anderson Can Ctr$7,842,501
- Alexander Egbe · Mayo Clinic Rochester$7,415,297
- Daniel Timms · Bivacor, Inc.$7,380,386
Research focus
Heart FailureIncidenceEfracHeart Dimension/SizeHospitalizationHourCommercial ApplicationEffective TherapyExtracellular MatrixHeartHeart TransplantationBiocompatible MaterialsAcuteBiomedical EngineeringAdultClinical TrialsDesignCardiacEpidemicCardiac MyocytesFibroblastsGrowthAmericanInjectable
Grant awards (2)
Evaluating Early and Late Functional, Immune and Angiogenic Responses to Injected Cardiac Fibroblast Derived Matrix in a Myocardial Infarction Model$337,094
R43 · FY2022 · HL · contact PI
iPSC-derived cardiac fibroblast extracellular matrix for cardiac cell therapy$320,678
R43 · FY2021 · HL · contact PI